NKX2-1 and diffuse large B-cell lymphoma: In this study, the authors found an aberrant activity of NKX2-1 by in silico expression analysis performed in 204 DLBCL patient samples and suggested that the permissive chromatin structure at the NKX2-1 gene may be associated with deregulation of histone ubiquitination enzymes in DLBCL.